Aims To investigate the acute effects of prostacyclin (FlolanA) on renal haemodynamics, renal tubular function, plasma concentration of angiotensin II (Ang II), aldosterone (Aldo), atrial natriuretic peptide (ANP), arginine vasopressin (AVP), mean arterial blood pressure (MBP), and heart rate (HR). Methods Thirteen healthy control subjects were investigated on two separate occasions in a placebo controlled, randomized, dose-response study of the effect of intravenous infusion of prostacyclin (PGI 2 , FlolanA, 2, 4 and 8 ng kg −1 min −1 ). Conclusions Infusion of prostacyclin in healthy control subjects increases renal plasma flow, angiotensin II, atrial natriuretic peptide, and heart rate and decreases mean blood pressure. Furthermore prostacyclin infusion does not change net sodium excretion in healthy controls.Keywords: prostacylin, prostaglandins, glomerular filtration rate, renal plasma flow, atrial natriuretic peptide, angiotensin II, aldosterone, vasopressin, blood pressure, heart rate, human available of renal haemodynamics, tubular handling of Introduction sodium and water, and plasma levels of several of the hormones of importance for renal sodium and water handling Prostaglandins (PG) are important for the maintenance of normal renal function, but their renal effects vary. Some during PGI 2 infusion. Also, to our knowledge no information exists about the interaction between PGI 2 on the one hand affect the vascular bed, while others have their main effects on the renal tubular handling of sodium and water [1][2][3].The and renal haemodynamics, vasoactive and sodium and water regulating hormones on the other hand in healthy control prostaglandin analogue prostacyclin (PGI 2 ) has been shown to affect both renal and systemic haemodynamics in humans subjects. Therefore we have investigated the acute effect of [4][5][6][7], although the information is ambiguous regarding the effect on renal tubular handling of sodium and water. In intravenous prostacyclin on 1) renal haemodynamics, 2) renal tubular function, 3) plasma concentration of some studies no effect has been reported [5,7,8] whereas an increase in sodium excretion has been reported in others angiotensin II (Ang II), aldosterone (Aldo), atrial natriuretic peptide (ANP) and arginine vasopressin (AVP), and 4) mean [6,9]. Furthermore, no simultaneous measurements are arterial blood pressure (MBP) and heart rate (HR) in a randomized placebo controlled dose-response study in